Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$1.59−0.19 (-10.67%)
Close on Nov 18, 2026Market cap $52.03MP/E –Yield –
Insight Molecular Diagnostics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Insight Molecular Diagnostics
Insight Molecular Diagnostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?